We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Genome sequence characterization of the unique recombinant vaccine-like lumpy skin disease virus strain Kurgan/2018

    In 2018, the molecular epidemiology of lumpy skin disease in Russia was characterized by a surge in novel recombinant vaccine-like strains causing...

    Alexander Sprygin, Antoinette van Schalkwyk, ... Ilya Chvala in Archives of Virology
    Article 09 January 2024
  2. Postbiotic-based recombinant receptor activator of NF-κB ligand enhanced oral vaccine efficiency in chicken

    Abstract

    Functional M cells are differentiated by receptor activator of NF-κB ligand (RANKL) and capture of luminal antigens to initiate immune...

    Biao Xuan, Jongbin Park, ... Eun Bae Kim in Applied Microbiology and Biotechnology
    Article Open access 26 June 2024
  3. Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccines

    Vaccines have proven effective in protecting populations against COVID-19, including the recombinant COVID-19 vaccine (Sf9 cells), the first approved...

    Wenxin Luo, Jiadi Gan, ... Lei Chen in Signal Transduction and Targeted Therapy
    Article Open access 14 February 2024
  4. Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types

    Formyl peptide receptor-like 1 inhibitor protein (FLIPr) is an immune evasion protein produced by Staphylococcus aureus , and FLIPr is a potential...

    Ming-Shu Hsieh, Mei-Yu Chen, ... Hsin-Wei Chen in npj Vaccines
    Article Open access 02 June 2023
  5. An M cell-targeting recombinant L. lactis vaccine against four H. pylori adhesins

    Abstract

    The acidic environment and enzyme degradation lead to oral vaccines often having little immune effect. Therefore, it is an attractive...

    Furui Zhang, Tianyi Shi, ... Le Guo in Applied Microbiology and Biotechnology
    Article Open access 23 February 2024
  6. Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2

    In response to COVID-19 pandemic, we have launched a vaccine development program against SARS-CoV-2. Here we report the safety, tolerability, and...

    Lorna Leal, Judit Pich, ... Elia Torroella in npj Vaccines
    Article Open access 29 September 2023
  7. Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial

    Considering that neutralizing antibody levels induced by two doses of the inactivated vaccine decreased over time and had fallen to low levels by 6...

    Tao Huang, Qianqian Hu, ... Lihui Gong in BMC Infectious Diseases
    Article Open access 19 April 2024
  8. Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus

    Hantaan virus (HTNV) is a pathogenic orthohantavirus prevalent in East Asia that is known to cause hemorrhagic fever with severe renal syndrome...

    Hui Zhang, He Liu, ... Fanglin Zhang in npj Vaccines
    Article Open access 10 February 2024
  9. A recombinant virus-like particle vaccine against adenovirus-7 induces a potent humoral response

    Adenoviruses (AdVs) cause infections in humans that range from mild to severe, and can cause outbreaks particularly in close contact settings....

    Ryan Mazboudi, Hannah Mulhall Maasz, ... Jose M. Galarza in npj Vaccines
    Article Open access 11 October 2023
  10. Production of Plant-Based Recombinant Vaccine Against Porcine Deltacoronavirus in the Form of Bacteria-Like Particles Using Lactococcus lactis

    Porcine deltacoronavirus (PDCoV) is an enteropathogenic swine coronavirus that causes severe diarrheal disease in suckling piglets and young pigs,...

    Gyeongryul Ryu, Gyeongik Ahn, ... Min Gab Kim in Journal of Plant Biology
    Article 18 January 2024
  11. Prophylactic Hepatitis E Vaccine

    The hepatitis E has been increasingly recognized as an underestimated global disease burden in recent years. Subpopulations with more serious...
    Jun Zhang, Zizheng Zheng, Ningshao Xia in Hepatitis E Virus
    Chapter 2023
  12. In silico analysis of HLA-1 and HLA-2 recognition of a designed recombinant human papillomavirus vaccine based on L1 protein HPV subtype 45

    Background

    Human leukocyte antigen (HLA) can bind and present the processed antigenic peptide derived from the vaccine to the T cell receptor, and...

    Asri Sulfianti, Nihayatul Karimah, Astutiati Nurhasanah in Journal of Genetic Engineering and Biotechnology
    Article Open access 13 December 2023
  13. Intranasal administration with recombinant vaccine PRVXJ-delgE/gI/TK-S induces strong intestinal mucosal immune responses against PDCoV

    Porcine deltacoronavirus (PDCoV) is a novel coronavirus that causes enteric diseases in pigs leading to substantial financial losses within the...

    Bingzhou Huang, Yao Huang, ... Zhiwen Xu in BMC Veterinary Research
    Article Open access 23 September 2023
  14. Activation and induction of antigen-specific T follicular helper cells play a critical role in recombinant SARS-CoV-2 RBD vaccine-induced humoral responses

    The role of follicular T helper (Tfh) cells in humoral response has been considered essential in recent years. Understanding how Tfh cells control...

    Songhao Yang, Liangwei Duan, ... Wei Zhao in Molecular Biomedicine
    Article Open access 19 October 2023
  15. Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance

    The influenza vaccine field has been constantly evolving to improve the speed, scalability, and flexibility of manufacturing, and to improve the...

    Arun B. Arunachalam, Penny Post, Deborah Rudin in npj Vaccines
    Article Open access 02 December 2021
  16. Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study

    The safety and efficacy of COVID-19 vaccines in the elderly, a high-risk group for severe COVID-19 infection, have not been fully understood. To...

    Hong-Hong Liu, Yunbo Xie, ... Fu-Sheng Wang in Signal Transduction and Targeted Therapy
    Article Open access 13 May 2024
Did you find what you were looking for? Share feedback.